• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Li Auto Inc.

    5/14/21 8:32:09 AM ET
    $LI
    Auto Manufacturing
    Consumer Discretionary
    Get the next $LI alert in real time by email
    SC 13D 1 tm2116436d1_sc13d.htm SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     
    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

     

    Li Auto Inc.

    (Name of Issuer)

     

    Class A ordinary shares, $0.0001 par value per share

    (Title of Class of Securities)

     

    50202M 102**

    (CUSIP Number)

     

    Xiang Li

    Amp Lee Ltd.

     

    11 Wenliang Street

    Shunyi District, Beijing 101399

    People’s Republic of China

    Tel: +86 (10) 8742-7209

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

     

    May 5, 2021

    (Date of Event Which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. x

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

    * This statement on Schedule 13D (the “Schedule 13D”) constitutes an initial Schedule 13D filed jointly by Mr. Xiang Li and Amp Lee Ltd. (together, the “Reporting Persons”), with respect to Class B ordinary shares, par value US$0.0001 per share of Li Auto Inc., a Cayman Islands company (the “Issuer”). Certain Class B ordinary shares beneficially owned by the Reporting Persons were previously reported on a Schedule 13G filed on February 5, 2021.

     

    ** There is no CUSIP number assigned to the Class A ordinary shares. CUSIP number 50202M 102 has been assigned to the American depositary shares (“ADSs”) of the issuer, which are quoted on the Nasdaq Stock Market under the symbol “LI.” Each ADS represents two Class A ordinary shares.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No. 50202M 102 13D Page 2 of 6 Pages

     

      1 Names of Reporting Persons
    Xiang Li
      2 Check the Appropriate Box if a Member of a Group
        (a)  o
        (b)  o
      3 SEC Use Only
      4 Source of Funds (See Instructions)
    SC
      5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
      6 Citizenship or Place of Organization
    People’s Republic of China
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    7 Sole Voting Power
    355,812,080(1)
    8 Shared Voting Power
    0
    9 Sole Dispositive Power
    464,369,480(1)
    10 Shared Dispositive Power
    0
      11 Aggregate Amount Beneficially Owned by Each Reporting Person
    464,369,480(1)
      12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
      13 Percent of Class Represented by Amount in Row (11)
    24.2%(2)
      14 Type of Reporting Person (See Instructions)
    IN
               

     

     

    (1) Represents (i) 355,812,080 Class B ordinary shares held by Amp Lee Ltd. and (ii) 108,557,400 Class B ordinary shares held by Amp Lee Ltd., which are acquired upon vesting of restricted shares pursuant to the Issuer’s 2021 Share Incentive Plan on May 5, 2021 (the “Award Shares”). Mr. Xiang Li has undertaken and covenanted that the Award Shares are subject to certain restrictions on, among others, transfer, voting, and receiving dividends. The restrictions may be released in tranches when certain performance-based conditions are met and an award premium for each share is paid. See Item 3 for more details. Amp Lee Ltd. is a British Virgin Islands company wholly owned by Cyric Point Enterprises Limited, which is wholly owned by Limind Trust, a trust established for the benefit of Mr. Xiang Li and his family. Mr. Xiang Li is the settlor and investment manager of Limind Trust, and has the power to direct the disposition and voting of the shares of the Issuer held by Limind Trust. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Xiang Li may be deemed to beneficially own all of the shares held by Amp Lee Ltd. Each holder of Class A ordinary shares of the Issuer is entitled to one vote per share and each holder of Class B ordinary shares of the Issuer is entitled to ten votes per share on all matters submitted to them for vote. Class B ordinary shares are convertible at any time by the holder thereof into Class A ordinary shares on a one-for-one basis. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances.

     

    (2) This calculation is based on a total of 1,917,845,710 ordinary shares issued and outstanding (being the sum of 1,453,476,230 Class A ordinary shares and 355,812,080 Class B ordinary shares issued and outstanding as of January 31, 2021 as well as the 108,557,400 Award Shares issued on May 5, 2021). These shares represent approximately 71.0% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming none of the performance-based conditions is met and no award premium is paid in respect of the Award Shares, or approximately 76.2% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming all of the performance-based conditions are met and the award premium is fully paid in respect of the Award Shares.

     

     

     

    CUSIP No. 50202M 102 13D Page 3 of 6 Pages

     

      1 Names of Reporting Persons
    Amp Lee Ltd.
      2 Check the Appropriate Box if a Member of a Group
        (a)  o
        (b)  o
      3 SEC Use Only
      4 Source of Funds (See Instructions)
    SC
      5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
      6 Citizenship or Place of Organization
    British Virgin Islands
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    7 Sole Voting Power
    355,812,080(1)
    8 Shared Voting Power
    0
    9 Sole Dispositive Power
    464,369,480(1)
    10 Shared Dispositive Power
    0
      11 Aggregate Amount Beneficially Owned by Each Reporting Person
    464,369,480(1)
      12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
      13 Percent of Class Represented by Amount in Row (11)
    24.2%(2)
      14 Type of Reporting Person (See Instructions)
    CO
               

     

     

    (1) Represents (i) 355,812,080 Class B ordinary shares held by Amp Lee Ltd. and (ii) 108,557,400 Class B ordinary shares held by Amp Lee Ltd. acquired upon vesting of restricted shares pursuant to the Issuer’s 2021 Share Incentive Plan on May 5, 2021 (the “Award Shares”). Mr. Xiang Li has undertaken and covenanted that the Award Shares are subject to certain restrictions on, among others, transfer, voting, and receiving dividends. The restrictions may be released in tranches when certain performance-based conditions are met and an award premium for each share is paid. See Item 3 for more details.

     

    (2) This calculation is based on a total of 1,917,845,710 ordinary shares issued and outstanding (being the sum of 1,453,476,230 Class A ordinary shares and 355,812,080 Class B ordinary shares issued and outstanding as of January 31, 2021 as well as the 108,557,400 Award Shares issued on May 5, 2021). These shares represent approximately 71.0% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming none of the performance-based conditions is met and no award premium is paid in respect of the Award Shares, or approximately 76.2% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming all of the performance-based conditions are met and the award premium is fully paid in respect of the Award Shares.

     

     

     

    CUSIP No. 50202M 102 13D Page 4 of 6 Pages

     

    Item 1.Security and Issuer

     

    This Schedule 13D relates to the ordinary shares of Li Auto Inc., a Cayman Islands company (the “Issuer”), whose principal executive offices are located at 11 Wenliang Street, Shunyi District, Beijing 101399, People’s Republic of China. The ordinary shares of the issuer consist of Class A ordinary shares (including Class A ordinary shares represented by ADSs and Class B ordinary shares), par value US$0.0001 each.

     

    The ADSs of the Issuer, each representing two Class A ordinary shares, are listed on the Nasdaq Global Select Market under the symbol “LI.”

     

    Item 2.Identity and Background

     

    (a): This Schedule 13D is being filed jointly by Mr. Xiang Li and Amp Lee Ltd. (together, the “Reporting Persons”, and each, a “Reporting Person”) pursuant to Rule 13d-1(k) promulgated by the SEC under Section 13 of the Act. The agreement between the Reporting Persons relating to the joint filing of this Schedule 13D is attached hereto as Exhibit A.

     

    Information with respect to each Reporting Person is given solely by such Reporting Person, and no Reporting Person assumes responsibility for the accuracy or completeness of the information concerning the other Reporting Person except as otherwise provided in Rule 13d-1(k).

     

    (b), (c), and (f): Mr. Xiang Li is a citizen of the People’s Republic of China. Mr. Xiang Li is the founder, chairman of the board of directors, and the chief executive officer of the Issuer. The business address of Mr. Xiang Li is 11 Wenliang Street, Shunyi District, Beijing 101399, People’s Republic of China.

     

    Amp Lee Ltd. is a British Virgin Islands company whose sole director is Mr. Xiang Li. Amp Lee Ltd. is wholly owned by Cyric Point Enterprises Limited, a British Virgin Islands company; Cyric Point Enterprises Limited is wholly owned by Limind Trust, a trust established for the benefit of Mr. Xiang Li and his family. Mr. Xiang Li is the settlor and investment manager of Limind Trust, and has the power to direct the disposition and voting of the shares of the Issuer held by Limind Trust. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Mr. Xiang Li may be deemed to beneficially own all of the shares held by Amp Lee Ltd. The registered office address of Amp Lee Ltd. is P.O. Box 3321, Drake Chambers, Road Town, Tortola, British Virgin Islands.

     

    (d) and (e): During the last five years, none of the Reporting Persons has been: (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

    Item 3. Source and Amount of Funds or Other Consideration

     

    Upon the completion of the Issuer’s IPO in July 2020, Mr. Xiang Li, as the founder, chairman of the board, and chief executive officer, held 355,812,080 Class B ordinary shares of the Issuer through Amp Lee Ltd., which was previously reported on a Schedule 13G filed on February 5, 2021.

     

    On March 8, 2021, the Issuer adopted a 2021 Share Incentive Plan (the “2021 Plan”) and granted options to purchase 108,557,400 Class B ordinary shares of the Issuer under the 2021 Plan to Mr. Xiang Li. The exercise price of the options is US$14.63 per share, or US$29.26 per ADS, which is equal to the average closing price for the Issuer’s ADSs of the thirty trading days immediately prior to the grant date. The options are vesting entirely contingent on achieving deliveries targets. The granted options are divided into six equal tranches, or 18,092,900 each. The first tranche will become vested when the aggregate number of the Issuer’s vehicle deliveries in any 12 consecutive months exceeds 500,000. The second to sixth tranches will become vested when the aggregate number of the Issuer’s vehicle deliveries in any 12 consecutive months exceeds 1,000,000, 1,500,000, 2,000,000, 2,500,000, and 3,000,000, respectively.

     

     

     

    CUSIP No. 50202M 102 13D Page 5 of 6 Pages

     

    On May 5, 2021, the Issuer approved to replace the options previously granted to Mr. Xiang Li on March 8, 2021 with 108,557,400 restricted Class B ordinary shares under the 2021 plan (the “Award Shares”), all of which immediately became vested upon grant on May 5, 2021. The Award Shares are issued as fully paid to Amp Lee Ltd. Mr. Xiang Li agrees, undertakes, and covenants not to transfer or dispose of, directly or indirectly, any interest in the Class B ordinary shares acquired upon vesting of the Award Shares, which are subject to certain performance conditions substantially similar to the vesting conditions of the options being replaced. In addition to the performance conditions, Mr. Xiang Li is required to pay US$14.63 per share, which is equal to the exercise price of the options being replaced, to have the relevant tranche of the Award Shares released from the restrictions. Mr. Xiang Li also agrees, undertakes, and covenants not to cast any vote or claim any dividend paid on any Award Shares before such number of Award Shares are released from the restrictions. Any Award Shares that are not released from the restrictions by March 8, 2031 are subject to compulsory repurchase by Issuer at their par value.

     

    Item 4.Purpose of Transaction.

     

    The information set forth in Item 3 is hereby incorporated by reference in its entirety.

     

    The beneficial ownership that is the subject of this Schedule 13D was acquired for long-term investment purposes. The Reporting Persons review its investments on a continuing basis. Depending on overall market conditions, performance and prospects of the Issuer, subsequent developments affecting the Issuer, other investment opportunities available to the Reporting Persons and other investment considerations, the Reporting Persons may hold, vote, acquire or dispose of or otherwise deal with securities of the Issuer. Any of the foregoing actions may be effected at any time or from time to time, subject to applicable law.

     

    Except as set forth above, none of the Reporting Persons has any present plan or proposal which related to or would result in any transaction, change or event specified in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to take such actions in the future as they deem appropriate, including changing the purpose described above or adopting plans or proposals with respect to one or more of the items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

     

    Item 5. Interest in Securities of the Issuer

     

    (a) and (b):

     

    The responses of each Reporting Person to Rows (7) through (13) of the cover pages of this Schedule 13D are hereby incorporated by reference in this Item 5.

     

    The percentage of the class of securities identified pursuant to Item 1 beneficially owned by each of the Reporting Persons is based on a total of 1,917,845,710 ordinary shares issued and outstanding (being the sum of 1,453,476,230 Class A ordinary shares and 355,812,080 Class B ordinary shares issued and outstanding as of January 31, 2021 as well as the 108,557,400 Award Shares issued on May 5, 2021). Each holder of Class A ordinary shares of the Issuer is entitled to one vote per share and each holder of Class B ordinary shares of the Issuer is entitled to ten votes per share on all matters submitted to them for vote. Class B ordinary shares are convertible at any time by the holder thereof into Class A ordinary shares on a one-for-one basis. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances.

     

    The shares beneficially owned by each of the Reporting Persons represent approximately 24.2% of the total issued and outstanding ordinary shares of the Issuer and represent approximately 71.0% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming none of the performance-based conditions is met and no award premium is paid in respect of the Award Shares, or approximately 76.2% of the aggregate voting power of the Issuer’s total issued and outstanding ordinary shares assuming all of the performance-based conditions are met and the award premium is fully paid in respect of the Award Shares.

     

    (c): Except as disclosed in this Schedule 13D, none of the Reporting Persons has effected any transaction in the ordinary shares of the Issuer during the past 60 days.

     

    (d): Except as disclosed in this Schedule 13D, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the ordinary shares beneficially owned by the Reporting Persons.

     

    (e): Not applicable.

     

     

     

     

    CUSIP No. 50202M 102 13D Page 6 of 6 Pages

     

    Item 6. Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer.

     

    The information set forth in Item 3 is hereby incorporated by reference in its entirety.

     

    To the best knowledge of the Reporting Persons, except as provided herein, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and between any of the Reporting Persons and any other person with respect to any securities of the Issuer, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies, or a pledge or contingency, the occurrence of which would give another person voting power over the securities of the Issuer.

     

    Item 7. Material to be Filed as Exhibits.

     

    Exhibit No. Description
    A Joint Filing Agreement dated May 14, 2021 by and between the Reporting Persons.
    B Restricted Shares Award Agreement dated May 5, 2021 between Xiang Li and the Issuer.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: May 14, 2021

     

      Amp Lee Ltd.
      By: /s/ Xiang Li
      Name: Xiang Li
      Title: Director
         
         
      Xiang Li
       
      /s/ Xiang Li

     

     

     

    Get the next $LI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LI

    DatePrice TargetRatingAnalyst
    3/17/2025Outperform → Neutral
    Macquarie
    2/28/2025$22.00 → $40.00Neutral → Overweight
    Analyst
    2/6/2025Neutral → Outperform
    Macquarie
    10/4/2024$25.00 → $33.00Outperform → Neutral
    Macquarie
    9/4/2024Buy → Neutral
    Citigroup
    5/22/2024$25.00Buy → Outperform
    CLSA
    4/25/2024$25.00Overweight → Equal Weight
    Barclays
    4/15/2024$40.00Outperform
    Macquarie
    More analyst ratings

    $LI
    SEC Filings

    See more
    • SEC Form 6-K filed by Li Auto Inc.

      6-K - Li Auto Inc. (0001791706) (Filer)

      5/8/25 9:16:38 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form 6-K filed by Li Auto Inc.

      6-K - Li Auto Inc. (0001791706) (Filer)

      5/1/25 7:20:48 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form 6-K filed by Li Auto Inc.

      6-K - Li Auto Inc. (0001791706) (Filer)

      4/22/25 7:23:37 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary

    $LI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Li Auto Inc. April 2025 Delivery Update

      BEIJING, China, April 30, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it delivered 33,939 vehicles in April 2025, representing a year-over-year increase of 31.6%. As of April 30, 2025, Li Auto's cumulative deliveries reached 1,260,675. Li Auto has remained the sales champion for SUVs priced above RMB200,000 over the past three consecutive quarters, maintaining the highest market share in both the RMB200,000 to RMB300,000 and RMB300,000 to RMB400,000 large SUV markets as well as the RMB400,000 to RMB500,000 full-size SUV market. This achievement was driven by the segment-lea

      4/30/25 10:00:00 PM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto Inc. to Hold Annual General Meeting on May 30, 2025

      BEIJING, China, April 22, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will hold an annual general meeting of the Company's shareholders (the "AGM") at 10:00 a.m. Beijing time on May 30, 2025 at 9/F, Office Tower C1, Oriental Plaza, 1 East Chang An Avenue, Beijing, China for the purposes of considering and, if thought fit, passing with or without amendments each of the proposed resolutions as set forth in the notice of the AGM (the "AGM Notice"). The AGM Notice, a circular in relation to the AGM, and the form of proxy for the AGM are available on the Company's website at h

      4/22/25 6:59:00 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto Inc. Files Its Annual Report on Form 20-F

      BEIJING, China, April 10, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 10, 2025. The annual report can be accessed on the Company's investor relations website at https://ir.lixiang.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company's Investor Relations Department a

      4/10/25 6:40:00 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary

    $LI
    Financials

    Live finance-specific insights

    See more
    • Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results

       Quarterly total revenues reached RMB44.3 billion (US$6.1 billion)1Quarterly deliveries reached 158,696 vehiclesFull year total revenues reached RMB144.5 billion (US$19.8 billion)Full year deliveries were 500,508 vehicles BEIJING, China, March 14, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter and full year ended December 31, 2024. Operating Highlights for the Fourth Quarter of 2024 and Full Year 2024 Total deliveries for the fourth quarter of 2024 were 158,696 vehicles, representing a 20.4% year-over-year increase.Total deli

      3/14/25 4:35:54 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 14, 2025

      BEIJING, China, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2024 before the U.S. market opens on Friday, March 14, 2025. The Company's management will hold an earnings conference call on Friday, March 14, 2025, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will rece

      2/27/25 3:30:00 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto Inc. Announces Unaudited Third Quarter 2024 Financial Results

      Quarterly total revenues reached RMB42.9 billion (US$6.1 billion)1Quarterly deliveries reached 152,831 vehicles BEIJING, China, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter ended September 30, 2024. Operating Highlights for the Third Quarter of 2024 Total deliveries for the third quarter of 2024 were 152,831 vehicles, representing a 45.4% year-over-year increase.   2024 Q3 2024 Q2 2024 Q1 2023 Q4  Deliveries 152,831 108,581 80,400 131,805               2023 Q3 2023 Q2 2023 Q1 2022 Q4  Deliveries 105,108 86,533 52,584 46

      10/31/24 4:30:36 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary

    $LI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $LI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form SC 13D/A filed by Li Auto Inc. (Amendment)

      SC 13D/A - Li Auto Inc. (0001791706) (Subject)

      4/1/22 7:25:41 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Li Auto Inc. (Amendment)

      SC 13D/A - Li Auto Inc. (0001791706) (Subject)

      8/13/21 4:02:03 PM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Li Auto Inc. (Amendment)

      SC 13D/A - Li Auto Inc. (0001791706) (Subject)

      5/14/21 1:23:35 PM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto downgraded by Macquarie

      Macquarie downgraded Li Auto from Outperform to Neutral

      3/17/25 7:37:53 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto upgraded by Analyst with a new price target

      Analyst upgraded Li Auto from Neutral to Overweight and set a new price target of $40.00 from $22.00 previously

      2/28/25 7:25:44 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary
    • Li Auto upgraded by Macquarie

      Macquarie upgraded Li Auto from Neutral to Outperform

      2/6/25 10:27:30 AM ET
      $LI
      Auto Manufacturing
      Consumer Discretionary

    $LI
    Leadership Updates

    Live Leadership Updates

    See more
    • Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

      The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme

      11/28/24 8:06:00 AM ET
      $BZ
      $HUYA
      $LI
      $PDD
      Computer Software: Programming Data Processing
      Technology
      Auto Manufacturing
      Consumer Discretionary